181 related articles for article (PubMed ID: 26945898)
1. The Interaction of CORM-2 with Block Copolymers Containing Poly(4-vinylpyridine): Macromolecular Scaffolds for Carbon Monoxide Delivery in Biological Systems.
Nguyen D; Adnan NN; Oliver S; Boyer C
Macromol Rapid Commun; 2016 May; 37(9):739-44. PubMed ID: 26945898
[TBL] [Abstract][Full Text] [Related]
2. Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery.
Qureshi OS; Zeb A; Akram M; Kim MS; Kang JH; Kim HS; Majid A; Han I; Chang SY; Bae ON; Kim JK
Eur J Pharm Biopharm; 2016 Nov; 108():187-195. PubMed ID: 27634645
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing Alginate Confinement and Polymer Coating of CO-Releasing Molecules Supported on Iron Oxide Nanoparticles To Trigger the CO Release by Magnetic Heating.
Meyer H; Winkler F; Kunz P; Schmidt AM; Hamacher A; Kassack MU; Janiak C
Inorg Chem; 2015 Dec; 54(23):11236-46. PubMed ID: 26595858
[TBL] [Abstract][Full Text] [Related]
4. A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species.
Lo Iacono L; Boczkowski J; Zini R; Salouage I; Berdeaux A; Motterlini R; Morin D
Free Radic Biol Med; 2011 Jun; 50(11):1556-64. PubMed ID: 21382478
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
6. The Intercalation of CORM-2 with Pharmaceutical Clay Montmorillonite (MMT) Aids for Therapeutic Carbon Monoxide Release.
Faizan M; Niazi KUK; Muhammad N; Hu Y; Wang Y; Lin D; Liu Y; Zhang W; Gao Z
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337099
[TBL] [Abstract][Full Text] [Related]
7. Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease.
Yin H; Fang J; Liao L; Nakamura H; Maeda H
J Control Release; 2014 Aug; 187():14-21. PubMed ID: 24852097
[TBL] [Abstract][Full Text] [Related]
8. Styrene-maleic acid copolymer-encapsulated carbon monoxide releasing molecule-2 (SMA/CORM-2) suppresses proliferation, migration and invasion of colorectal cancer cells in vitro and in vivo.
Lv C; Su Q; Fang J; Yin H
Biochem Biophys Res Commun; 2019 Dec; 520(2):320-326. PubMed ID: 31604526
[TBL] [Abstract][Full Text] [Related]
9. Dicarbonyl-bis(cysteamine)iron(II): a light induced carbon monoxide releasing molecule based on iron (CORM-S1).
Kretschmer R; Gessner G; Görls H; Heinemann SH; Westerhausen M
J Inorg Biochem; 2011 Jan; 105(1):6-9. PubMed ID: 21134596
[TBL] [Abstract][Full Text] [Related]
10. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
11. Interaction of carbon monoxide-releasing ruthenium carbonyl CORM-3 with plasma fibronectin.
Aki T; Unuma K; Noritake K; Kurahashi H; Funakoshi T; Uemura K
Toxicol In Vitro; 2018 Aug; 50():201-209. PubMed ID: 29580987
[TBL] [Abstract][Full Text] [Related]
12. Carbon monoxide-releasing micelles for immunotherapy.
Hasegawa U; van der Vlies AJ; Simeoni E; Wandrey C; Hubbell JA
J Am Chem Soc; 2010 Dec; 132(51):18273-80. PubMed ID: 21128648
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
Nielsen VG; Garza JI
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
[TBL] [Abstract][Full Text] [Related]
14. Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs).
Motterlini R; Sawle P; Hammad J; Mann BE; Johnson TR; Green CJ; Foresti R
Pharmacol Res; 2013 Feb; 68(1):108-17. PubMed ID: 23253427
[TBL] [Abstract][Full Text] [Related]
15. Effects of frequently applied carbon monoxide releasing molecules (CORMs) in typical CO-sensitive model systems - A comparative in vitro study.
Stucki D; Krahl H; Walter M; Steinhausen J; Hommel K; Brenneisen P; Stahl W
Arch Biochem Biophys; 2020 Jul; 687():108383. PubMed ID: 32335048
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
18. Oral drug delivery of therapeutic gases - carbon monoxide release for gastrointestinal diseases.
Steiger C; Lühmann T; Meinel L
J Control Release; 2014 Sep; 189():46-53. PubMed ID: 24969354
[TBL] [Abstract][Full Text] [Related]
19. The anticoagulant effect of Apis mellifera phospholipase A
Nielsen VG
J Thromb Thrombolysis; 2020 Jan; 49(1):100-107. PubMed ID: 31679116
[TBL] [Abstract][Full Text] [Related]
20. Recent progress on anti-nociceptive effects of carbon monoxide releasing molecule-2 (CORM-2).
Khir NAM; Noh ASM; Long I; Zakaria R; Ismail CAN
Mol Cell Biochem; 2024 Mar; 479(3):539-552. PubMed ID: 37106243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
